Malaria eradication and elimination

views on how to translate a vision into reality

Marcel Tanner, Brian Greenwood, Christopher Whitty, Evelyn K Ansah, Ric Price, Arjen Dondorp, L Vonseidlein, J Kevin Baird, James G Beeson, Freya J.I. Fowkes, Janet Hemingway, Kevin Marsh, Faith Osier

    Research output: Contribution to journalArticleResearchpeer-review

    3 Downloads (Pure)

    Abstract

    Although global efforts in the past decade have halved the number of deaths due to malaria, there are still an estimated 219 million cases of malaria a year, causing more than half a million deaths. In this forum article, we asked experts working in malaria research and control to discuss the ways in which malaria might eventually be eradicated. Their collective views highlight the challenges and opportunities, and explain how multi-factorial and integrated processes could eventually make malaria eradication a reality.
    Original languageEnglish
    Pages (from-to)1-22
    Number of pages22
    JournalBMC Medicine
    Volume13
    Issue number167
    DOIs
    Publication statusPublished - 25 Jul 2015

    Fingerprint

    Malaria
    Research

    Cite this

    Tanner, M., Greenwood, B., Whitty, C., Ansah, E. K., Price, R., Dondorp, A., ... Osier, F. (2015). Malaria eradication and elimination: views on how to translate a vision into reality. BMC Medicine, 13(167), 1-22. https://doi.org/10.1186/s12916-015-0384-6
    Tanner, Marcel ; Greenwood, Brian ; Whitty, Christopher ; Ansah, Evelyn K ; Price, Ric ; Dondorp, Arjen ; Vonseidlein, L ; Baird, J Kevin ; Beeson, James G ; Fowkes, Freya J.I. ; Hemingway, Janet ; Marsh, Kevin ; Osier, Faith. / Malaria eradication and elimination : views on how to translate a vision into reality. In: BMC Medicine. 2015 ; Vol. 13, No. 167. pp. 1-22.
    @article{339651ac7d7d4d6fa8e5d450e8de1555,
    title = "Malaria eradication and elimination: views on how to translate a vision into reality",
    abstract = "Although global efforts in the past decade have halved the number of deaths due to malaria, there are still an estimated 219 million cases of malaria a year, causing more than half a million deaths. In this forum article, we asked experts working in malaria research and control to discuss the ways in which malaria might eventually be eradicated. Their collective views highlight the challenges and opportunities, and explain how multi-factorial and integrated processes could eventually make malaria eradication a reality.",
    keywords = "apical membrane antigen 1, artemether plus benflumetol, artemisinin derivative, chloroquine, dihydroartemisinin plus piperaquine, malaria vaccine, merozoite surface protein 2, primaquine, antimalarial drug resistance, Article, bed net, drug efficacy, drug tolerability, human, incidence, indoor residual spraying, low drug dose, malaria, malaria control, malaria falciparum, microscopy, nonhuman, parasite clearance, parasite transmission, Plasmodium falciparum, Plasmodium vivax, Plasmodium vivax malaria, polymerase chain reaction, rapid test, serodiagnosis, single drug dose, vaccination",
    author = "Marcel Tanner and Brian Greenwood and Christopher Whitty and Ansah, {Evelyn K} and Ric Price and Arjen Dondorp and L Vonseidlein and Baird, {J Kevin} and Beeson, {James G} and Fowkes, {Freya J.I.} and Janet Hemingway and Kevin Marsh and Faith Osier",
    year = "2015",
    month = "7",
    day = "25",
    doi = "10.1186/s12916-015-0384-6",
    language = "English",
    volume = "13",
    pages = "1--22",
    journal = "BMC Medicine",
    issn = "1741-7015",
    publisher = "BioMed Central",
    number = "167",

    }

    Tanner, M, Greenwood, B, Whitty, C, Ansah, EK, Price, R, Dondorp, A, Vonseidlein, L, Baird, JK, Beeson, JG, Fowkes, FJI, Hemingway, J, Marsh, K & Osier, F 2015, 'Malaria eradication and elimination: views on how to translate a vision into reality', BMC Medicine, vol. 13, no. 167, pp. 1-22. https://doi.org/10.1186/s12916-015-0384-6

    Malaria eradication and elimination : views on how to translate a vision into reality. / Tanner, Marcel; Greenwood, Brian; Whitty, Christopher; Ansah, Evelyn K; Price, Ric; Dondorp, Arjen; Vonseidlein, L; Baird, J Kevin; Beeson, James G; Fowkes, Freya J.I.; Hemingway, Janet; Marsh, Kevin; Osier, Faith.

    In: BMC Medicine, Vol. 13, No. 167, 25.07.2015, p. 1-22.

    Research output: Contribution to journalArticleResearchpeer-review

    TY - JOUR

    T1 - Malaria eradication and elimination

    T2 - views on how to translate a vision into reality

    AU - Tanner, Marcel

    AU - Greenwood, Brian

    AU - Whitty, Christopher

    AU - Ansah, Evelyn K

    AU - Price, Ric

    AU - Dondorp, Arjen

    AU - Vonseidlein, L

    AU - Baird, J Kevin

    AU - Beeson, James G

    AU - Fowkes, Freya J.I.

    AU - Hemingway, Janet

    AU - Marsh, Kevin

    AU - Osier, Faith

    PY - 2015/7/25

    Y1 - 2015/7/25

    N2 - Although global efforts in the past decade have halved the number of deaths due to malaria, there are still an estimated 219 million cases of malaria a year, causing more than half a million deaths. In this forum article, we asked experts working in malaria research and control to discuss the ways in which malaria might eventually be eradicated. Their collective views highlight the challenges and opportunities, and explain how multi-factorial and integrated processes could eventually make malaria eradication a reality.

    AB - Although global efforts in the past decade have halved the number of deaths due to malaria, there are still an estimated 219 million cases of malaria a year, causing more than half a million deaths. In this forum article, we asked experts working in malaria research and control to discuss the ways in which malaria might eventually be eradicated. Their collective views highlight the challenges and opportunities, and explain how multi-factorial and integrated processes could eventually make malaria eradication a reality.

    KW - apical membrane antigen 1

    KW - artemether plus benflumetol

    KW - artemisinin derivative

    KW - chloroquine

    KW - dihydroartemisinin plus piperaquine

    KW - malaria vaccine

    KW - merozoite surface protein 2

    KW - primaquine

    KW - antimalarial drug resistance

    KW - Article

    KW - bed net

    KW - drug efficacy

    KW - drug tolerability

    KW - human

    KW - incidence

    KW - indoor residual spraying

    KW - low drug dose

    KW - malaria

    KW - malaria control

    KW - malaria falciparum

    KW - microscopy

    KW - nonhuman

    KW - parasite clearance

    KW - parasite transmission

    KW - Plasmodium falciparum

    KW - Plasmodium vivax

    KW - Plasmodium vivax malaria

    KW - polymerase chain reaction

    KW - rapid test

    KW - serodiagnosis

    KW - single drug dose

    KW - vaccination

    U2 - 10.1186/s12916-015-0384-6

    DO - 10.1186/s12916-015-0384-6

    M3 - Article

    VL - 13

    SP - 1

    EP - 22

    JO - BMC Medicine

    JF - BMC Medicine

    SN - 1741-7015

    IS - 167

    ER -